Candel Therapeutics Inc. (NASDAQ: CADL)
$7.29
+0.6700 ( +10.12% ) 733.3K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$7.29
Previous close
$6.62
Volume
733.3K
Market cap
$216.92M
Day range
$6.47 - $7.34
52 week range
$0.66 - $14.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
8-k | 8K-related | 11 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |